Truist on Apogee Therapeutics Inc (APGE) amid 22pct Gain: ' we see ~10–20% upside for the shares today'
Tweet Send to a Friend
Truist Securities analyst Danielle Brill reiterated a Hold rating and $83.00 price target on Apogee Therapeutics Inc (NASDAQ: APGE)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
